Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis

scientific article published on February 2002

Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JNR.10139
P698PubMed publication ID11835313

P2093author name stringGuy Weinberg
Douglas L Feinstein
Michael T Heneka
Aigang Lu
Frank R Sharp
Cinzia Dello Russo
Patricia Murphy
Anthony Sharp
Vitaliy Gavrilyuk
Joseph Shin
P2860cites workInhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformationQ24564127
Non-steroidal anti-inflammatory drugs inhibit the expression of cytokines and induce HSP70 in human monocytesQ28162595
Herbimycin, a new antibiotic produced by a strain of StreptomycesQ28327610
Inhibitory and stimulatory effects of lactacystin on expression of nitric oxide synthase type 2 in brain glial cells. The role of Ikappa B-betaQ28569263
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluidsQ29616817
Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1.Q32049448
HSP90 interacts with and regulates the activity of heat shock factor 1 in Xenopus oocytesQ33776598
Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activityQ33888219
Cell mediators of inflammation in the Alzheimer disease brainQ33941244
Series introduction: the transcription factor NF-kappaB and human diseaseQ34116362
Interleukin 1 in the brain: biology, pathology and therapeutic targetQ34117586
NF-kappaB in neuronal plasticity and neurodegenerative disordersQ34131754
I kappa B-independent control of NF-kappa B activity by modulatory phosphorylationsQ34179362
Role of nuclear factor kappa B in neuropathological mechanismsQ34361301
Immunological aspects of microglia: relevance to Alzheimer's diseaseQ34386107
Cloning and expression of inducible nitric oxide synthase from rat astrocytes.Q36674680
Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virusQ36915975
Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures.Q37302901
Mechanism of quercetin-induced suppression and delay of heat shock gene expression and thermotolerance development in HT-29 cellsQ38305122
Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophagesQ40786648
Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationshipsQ40935078
Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine releaseQ41010028
Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycinQ41168181
The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycinQ42826312
Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compoundsQ45307438
Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG).Q46595832
Suppression of glial nitric oxide synthase induction by heat shock: effects on proteolytic degradation of IkappaB-alpha.Q47697721
Potent inhibition of inducible nitric oxide synthase by geldanamycin, a tyrosine kinase inhibitor, in endothelial, smooth muscle cells, and in rat aortaQ48801680
The heat shock response reduces myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in miceQ48921063
Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFkappaB activationQ48960660
P433issue4
P304page(s)461-470
P577publication date2002-02-01
P1433published inJournal of Neuroscience ResearchQ6295654
P1476titleSuppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis
P478volume67

Reverse relations

cites work (P2860)
Q4037491517-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration
Q39715278Activation of the stress protein response inhibits the STAT1 signalling pathway and iNOS function in alveolar macrophages: role of Hsp90 and Hsp70.
Q28076199Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies
Q36657652Autoimmune modulation of astrocyte-mediated homeostasis.
Q44757991Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease
Q39281800Heat shock protein 90 inhibitor attenuates renal fibrosis through degradation of transforming growth factor-β type II receptor.
Q28300549Inducible heat shock protein 70 kD and inducible nitric oxide synthase in hemorrhage/resuscitation-induced injury
Q48253153Interleukin-12 induces mild experimental allergic encephalomyelitis following local central nervous system injury in the Lewis rat.
Q36495265Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein
Q36759577Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
Q44478728Physical activity alters the brain Hsp72 and IL-1beta responses to peripheral E. coli challenge
Q27000682Positive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overview
Q92553022Regional differences in the inflammatory and heat shock response in glia: implications for ALS
Q37010253The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE.
Q33531705To fold or not to fold: modulation and consequences of Hsp90 inhibition

Search more.